Today's featured articles
Circassia Pharmaceuticals, the specialist drugs company backed by fund manager Neil Woodford, has high hopes for the cat allergy treatment it aims to launch next year.
Edinburgh-based Baillie Gifford joins the band of investment groups revealing how actively managed their funds really are.
Investors pulled a net £4.7 billion from UK funds in January, the biggest outflow on record.
Some questioned Dale Nicholls' appointment as Anthony Bolton's successor on Fidelity China Special Situations, but he has delivered strong returns.
Our daily roundup of analyst commentary on shares, also including National Express and Robert Walters.
The Nasdaq resumed its recent advance, boosted by a rebound in Apple Inc. shares.
And RBS moves to speed up full return to private sector as it unveiled a new restructuring plan that aims to cut costs and boost capital.
RBS results fall short of expectations while Standard Chartered jumps on announcement of new boss.
Bond fund manager Alexander Pelteshki attacks Lloyds bank's plan to resume its dividend, saying it is not looking after its lenders.
British Assets shareholders have backed plans to give the underperforming global fund a new pension mandate under BlackRock.
Activist investor Edward Bramson has raised £100 million to renew his campaign against Electra Private Equity investment trust.
Serious Fraud Office searches two properties in south east as part of investigation into Global Forestry Investments.
Investment trusts have a good reputation for skating over the thin ice of stock markets to deliver investment income: but which are the best?
Our daily roundup of analyst commentary on shares, also including Henderson and Rightmove.
And Germany has sold five-year debt at a negative yield for the first time.
Declines in Hewlett-Packard Co. and Apple Inc. offset gains among retailers amid corporate earnings.